Global Anti-Ageing Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Anti-Ageing Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Anti-aging drugs are used to slow down or reverse the processes of aging to extend the lifespan. Aging, is that damage to the body’s macromolecules, cells, tissues, which is facilitated by genomic instability, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, oxidation damage by free radicals etc
Anti-Ageing Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Ageing Drugs market is projected to reach US$ 140690 million in 2034, increasing from US$ 82060 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2034. Demand from Skin and Hair are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Ageing Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-Ageing Drugs key manufacturers include Nu Skin, BIOTIME, Elysium Health, La Roche-Posay and DermaFix, etc. Nu Skin, BIOTIME, Elysium Health are top 3 players and held % sales share in total in 2022.
Anti-Ageing Drugs can be divided into Hormonal Therapy, Antioxidants, Enzymes and Stem Cells, etc. Hormonal Therapy is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-Ageing Drugs is widely used in various fields, such as Skin, Hair and Others,, etc. Skin provides greatest supports to the Anti-Ageing Drugs industry development. In 2022, global % sales of Anti-Ageing Drugs went into Skin filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Ageing Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
Segment by Type
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others
Skin
Hair
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Anti-Ageing Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Ageing Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Ageing Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anti-Ageing Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Ageing Drugs introduction, etc. Anti-Ageing Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Anti-Ageing Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.![](http://localhost/mraccuracy/images/About Report.webp)
Anti-Ageing Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Ageing Drugs market is projected to reach US$ 140690 million in 2034, increasing from US$ 82060 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2034. Demand from Skin and Hair are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Ageing Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-Ageing Drugs key manufacturers include Nu Skin, BIOTIME, Elysium Health, La Roche-Posay and DermaFix, etc. Nu Skin, BIOTIME, Elysium Health are top 3 players and held % sales share in total in 2022.
Anti-Ageing Drugs can be divided into Hormonal Therapy, Antioxidants, Enzymes and Stem Cells, etc. Hormonal Therapy is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-Ageing Drugs is widely used in various fields, such as Skin, Hair and Others,, etc. Skin provides greatest supports to the Anti-Ageing Drugs industry development. In 2022, global % sales of Anti-Ageing Drugs went into Skin filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Ageing Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Nu Skin
BIOTIME
Elysium Health
La Roche-Posay
DermaFix
Segment by Type
Hormonal Therapy
Antioxidants
Enzymes
Stem Cells
Others
Segment by Application
Skin
Hair
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Anti-Ageing Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Ageing Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Ageing Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anti-Ageing Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Ageing Drugs introduction, etc. Anti-Ageing Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Anti-Ageing Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
![](http://localhost/mraccuracy/images/About Report.webp)